Marinus Pharmaceuticals (United States)
- Research works
- 34 ▲ 119% vs 2013–17
- Citations
- 522 15.4 per fractional work
- Top-10% rate
- 7.2% record average 16.5%
- Open access
- 33% world 28%
Not ranked overall: Marinus Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 17.6×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 17.6×
- Medicine 3.1×
- Neuroscience 2.8×
- Economics, Econometrics and Finance 1.1×
- Biochemistry, Genetics and Molecular Biology 1.0×
- Chemistry 0.9×
- Decision Sciences 0.7×
- Materials Science 0.6×
- Social Sciences 0.5×
- Engineering 0.5×
- Computer Science 0.4×
- Immunology and Microbiology 0.3×
- Agricultural and Biological Sciences 0.3×
Which keywords describe research at Marinus Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Antiepileptic Drugs, Neurological Disorders, Dendritic Spines, Classification, Synaptic Plasticity, Inflammation, Epilepsy and Neurobiology.
- CO2 Enrichment
- Genetic Mutations
- Breast Cancer
- Cognitive Function
- Neurotransmission
- Status Epilepticus
- Neurobiology
- Synaptic Plasticity
- Dendritic Spines
- Antiepileptic Drugs
- Inflammation
- Neurological Disorders
- Classification
- Epilepsy
- Seizures
- GABAergic
- Epidemiology
- Oxidative Stress
- Climate Change
- Crystal Engineering
- Ozone Effects
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 21 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 21 words, with their numbers
- Inflammation4▲ 4.7×6 topics
- Antiepileptic Drugs4▲ 106×2 topics
- Neurological Disorders3▲ 14×5 topics
- Dendritic Spines3▲ 58×2 topics
- Classification3▲ 24×2 topics
- Synaptic Plasticity3▲ 28×3 topics
- Epilepsy3▲ 67×3 topics
- Neurobiology3▲ 24×2 topics
- Seizures3▲ 108×1 topic
- Status Epilepticus3▲ 143×1 topic
- GABAergic3▲ 59×1 topic
- Neurotransmission3▲ 59×1 topic
- Epidemiology2▲ 1.46×8 topics
- Cognitive Function2▲ 22×3 topics
- Oxidative Stress2▲ 2.3×5 topics
- Breast Cancer1▲ 12×3 topics
- Climate Change1▲ 1.35×3 topics
- Genetic Mutations1▲ 6.7×6 topics
- Crystal Engineering1▲ 27×2 topics
- CO2 Enrichment1▲ 150×1 topic
- Ozone Effects1▲ 150×1 topic
Which research topics does Marinus Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Epilepsy research and treatment, Pharmacological Effects and Toxicity Studies, Drug Solubulity and Delivery Systems and Cancer-related cognitive impairment studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Epilepsy research and treatment Psychiatry and Mental health 2 works
- 2 Pharmacological Effects and Toxicity Studies Pediatrics, Perinatology and Child Health 1 works
- 3 Drug Solubulity and Delivery Systems Pharmaceutical Science 0 works
- 4 Cancer-related cognitive impairment studies Pulmonary and Respiratory Medicine 0 works
- 5 Neuroscience and Neuropharmacology Research Cellular and Molecular Neuroscience 0 works
- 6 Industrial and Mining Safety Safety, Risk, Reliability and Quality 0 works
- 7 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
- 8 Intellectual Property Rights and Media Political Science and International Relations 0 works
- 9 Traumatic Brain Injury and Neurovascular Disturbances Neurology 0 works
- 10 Genetics and Neurodevelopmental Disorders Genetics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Marinus Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 119% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Radnor
- Villanova University
- Eastern University
- Main Line Health
- Cabrini University
- Devereux
- Association for Frontotemporal Degeneration
- VWR International (United States)
- Zynerba Pharmaceuticals (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.